Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Health & MedicineOne-Off1aManifold MarketsSans KYCDonnées de résolution vérifiéesAssez bien calibréPrévision communautaire actuelleNon 77.9%
Prévisionnistes
14
Type de question
binary
Méthodologie
Play-money forecasting platform
Type de source
Prévision
Données du marché
Mis à jour il y a 13 heures
Obsolète21 févr. 23, 20:23 UTC31 déc. 27, 22:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Will FDA approve any mRNA vaccine against any type of human papillomavirus infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against melanoma before 2028?
Manifold MarketsWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve a cure for Type 1 diabetes before 2033?
KalshiRègles
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
Marchés ouverts
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume total
- 15,6 M €
- Volume 24h
- 18,3 k €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volume total
- 1,6 M €
- Volume 24h
- 5,2 k €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 résultats de plus
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Volume total
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volume total
- 916 k €
- Volume 24h
- 1,5 k €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 résultats de plus
- Volume total
- 863,6 k €
- Volume 24h
- 1 k €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
Questions fréquentes
- Quelles sont les probabilités actuelles pour Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? ?
- Manifold Markets cote No à 78% au 8 septembre 2026.
- Quand Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? sera-t-il résolu ?
- Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? doit être résolu le 31 décembre 2027.
- Comment Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028? est-il réglé ?
- Manifold Markets règle ce marché comme suit : Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of any type of herpes simplex infection in the United States before January 1, 2028.